(Q37650570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

review article

1 reference

title

Genetic predisposition of life-threatening antiepileptic-induced skin reactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

Yuan-Tsong Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Wen-Hung Chung

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

15-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

Clinical heterogeneity of drug hypersensitivity

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

CNS adverse events associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Anticonvulsant hypersensitivity syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Idiosyncratic adverse reactions to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Delayed Drug Hypersensitivity Reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Antiepileptic drug-induced hypersensitivity syndrome reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Epidemiological assessment of drug-induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Comparison and predictors of rash associated with 15 antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Rash from antiepileptic drugs: influence by gender, age, and learning disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Antiepileptic drugs and mood stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Painful diabetic neuropathy: treatment and future aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Pharmacogenetics and geographical ancestry: implications for drug development and global health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Human leukocyte antigens and drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Cross-reactivity among drugs: clinical problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Hypersensitivity to aromatic anticonvulsants: in vivo and in vitro cross-reactivity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Cross-sensitivity of skin rashes with antiepileptic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Cross-reactivity pattern of rash from current aromatic antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

Oxcarbazepine-induced Stevens-Johnson syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903427969

10.1517/14740330903427969

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001755%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference